Evidence map›Paper›PMID 30753265›Full record

ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2019

Searching for the needle in the haystack: deconvoluting the evolutionary dynamics of residual disease in human glioblastoma.

S T C Shepherd, K Litchfield, S Turajlic

Open access · hybridAbstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of oncology : official journal of the European Society for Medical Oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Tumor DNA From TumorFrontiers in oncology · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

S T C ShepherdThe Renal and Melanoma Unit, The Royal Marsden NHS Foundation Trust, London; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
K LitchfieldCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
S TurajlicThe Renal and Melanoma Unit, The Royal Marsden NHS Foundation Trust, London; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. Electronic address: samra.turajlic@crick.ac.uk.
The Francis Crick Institute · GB

Funding

Cancer Research UK C50947/A18176Medical Research Council MR/P014712/1Medical Research [UK] MR/P014712/1Wellcome Trust 202778/Z/16/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GlioblastomaHumansNeoplasm, Residual

Identifiers

PMID30753265
PMCPMC6442653
OpenAlexW2911512712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.